TGFB1 and neoplasm: In cancer, the TGF-β pathway is frequently co-opted by tumors to create an immunosuppressive microenvironment that facilitates immune evasion (Fig. 5c), promoting tumor growth, metastasis, and resistance to therapies.306,307